View all cases
ORD 63909/2024
—·EP3831282: REMOTE MONITORING OF ANALYTE MEASUREMENTS
- Case details
- Status—ActionProcedural applicationCategoryCase Management Orders
- Parties
- ClaimantsReps: Anne-Charlotte le Bihan (Bird & Bird LLP); Laurent Labatte (Bird & Bird LLP); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)Respondents
- Abbott Logistics B.V.
- Abbott Diagnostics GmbH
- Abbott France
- Abbott Oy
- Abbott Diabetes Care Inc.
- Newyu, Inc.
- Abbott B.V.
- Abbott s.r.l.
- Abbott Scandinavia Aktiebolag
- Abbott Gesellschaft m.b.H.
- Abbott Laboratories A/S
- Abbott GmbH
- Abbott Laboratories
Reps: Christian Dekoninck (Taylor Wessing); François Pochart (August Debouzy) - Division
- Paris LD
- Judges
- Camille Lignieres · Judge-Rapporteur
- Technology
- Healthcare Informatics
- Language
- —
- First decided
- Dec 11, 2024
Claims
At issue1
Revokedall
Notes: Paris Local Division revoked EP 3 831 282 entirely for added matter; claim 1 as granted and as amended per AR1, AR2, AR3 all failed; infringement action dismissed for lack of legal basis.
Decisions
- 2024-12-11RevokedInfringement meritsGeneric Order
Decision on the merits from the Paris Local Division (UPC_CFI_395/2023) delivered on 11 December 2024 in DexCom's infringement action against Abbott entities concerning EP 3 831 282. The Court found the patent invalid in its entirety — neither as granted nor as amended by auxiliary requests 1, 2 or 3 — due to added subject-matter under Art. 138(1)(c) EPC. The infringement action was dismissed for lack of legal basis. DexCom was ordered to bear Abbott's costs, with the amount to be determined in separate proceedings.
Legal issues:Added matter (Art. 138(1)(c) EPC)Auxiliary requests for patent amendmentAdmissibility of new grounds for revocation in rejoinder (R. 9.2 RoP)Claim interpretation (whole-content approach)Inventive step (Art. 56 EPC)
Documents
- 9DC31A56B02BC3E943FBD9B92216AE51_en.pdf2024-12-11EN